Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Laboratorio Reig JofreXMAD:RJF 80 Days Inventory is 170.36 as of Mar. 2026, which is 0% below its 10-year median of 171.00. GuruFocus rates XMAD:RJF with a GF Score™ of 80/100 and a GF Value™ of €2.72 (Fairly Valued). The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Laboratorio Reig Jofre ranks better than 51.68% on this metric.
The historical rank and industry rank for Laboratorio Reig Jofre's Days Inventory or its related term are showing as below:
XMAD:RJF'
s Days Inventory Range Over the Past 10 Years
Min: 146.18 Med: 171 Max: 184.14
Current: 159.11
During the past 13 years, Laboratorio Reig Jofre's highest Days Inventory was 184.14. The lowest was 146.18. And the median was 171.00.
XMAD:RJF's Days Inventory is ranked better than 51.68% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs XMAD:RJF: 159.11
Laboratorio Reig Jofre's Days Inventory
declined
from Mar. 2025 (175.31) to Mar. 2026 (170.36).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Laboratorio Reig Jofre's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Laboratorio Reig Jofre's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.76.
Laboratorio Reig Jofre (XMAD:RJF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Laboratorio Reig Jofre's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Laboratorio Reig Jofre's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Laboratorio Reig Jofre Days Inventory Related Terms
Laboratorio Reig Jofre Days Inventory Historical Data
* Premium members only.
The historical data trend for Laboratorio Reig Jofre's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:RJF vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Reig Jofre Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Days Inventory distribution charts can be found below:
* The bar in red indicates where Laboratorio Reig Jofre's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorio Reig Jofre (XMAD:RJF) has a Days Inventory of 170.36 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Laboratorio Reig Jofre and its competitors. This is near median its historical median of 171.00. Over the past decade, Laboratorio Reig Jofre's Days Inventory has ranged from 146.18 to 184.14. According to the industry distribution chart, Laboratorio Reig Jofre ranks #446 out of 923 companies in the Drug Manufacturers industry, placing it in the top 48.3%.
Is Laboratorio Reig Jofre's Days Inventory too high?
Laboratorio Reig Jofre's current Days Inventory of 170.36 is near median its 10-year median of 171.00. Over the past 10 years, this metric has ranged from a low of 146.18 to a high of 184.14. The Drug Manufacturers industry median Days Inventory is 164.38. Laboratorio Reig Jofre's value of 170.36 is 3.6% above this industry median. Based on the distribution chart, Laboratorio Reig Jofre ranks #446 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Laboratorio Reig Jofre has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Reig Jofre's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Laboratorio Reig Jofre ranks #446 out of 923 companies for Days Inventory. This puts Laboratorio Reig Jofre in the upper half of its industry. The industry median Days Inventory is 164.38. Laboratorio Reig Jofre's value of 170.36 is 3.6% above this benchmark. Historically, Laboratorio Reig Jofre's own Days Inventory has ranged from 146.18 to 184.14 over the past decade. While the company's 10-year median is 171.00 vs. the industry median of 164.38, Laboratorio Reig Jofre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorio Reig Jofre's current Days Inventory of 170.36 is 3.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Laboratorio Reig Jofre and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Reig Jofre's current Days Inventory is 170.36, which is near median its own 10-year median of 171.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Reig Jofre stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Reig Jofre (XMAD:RJF) is currently considered Fairly Valued. The stock's GF Value™ is €2.72, compared to a current price of €2.62 — trading 3.7% below its estimated fair value. The current Days Inventory is 170.36, which is near median its 10-year median of 171.00 and 3.6% above the Drug Manufacturers industry median of 164.38. Laboratorio Reig Jofre's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Laboratorio Reig Jofre (XMAD:RJF), the current Days Inventory is 170.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorio Reig Jofre (XMAD:RJF) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorio Reig Jofre stock appears to be undervalued.
The current stock price of €2.62 is trading 3.7% below its estimated GF Value™ of €2.72.
GuruFocus considers Laboratorio Reig Jofre to be Fairly Valued.
Key valuation signals for XMAD:RJF:
Days Inventory: 170.36 (near median its 10-year median of 171.00)
GF Value™: €2.72 vs. price of €2.62 (3.7% below fair value)
Industry Position: 3.6% above the Drug Manufacturers median (#446 of 923)
No single metric tells the full story. See the XMAD:RJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
80GF Score
Get the complete analysis for XMAD:RJF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:RJF has been successfully added to your 
